RZV - ETF AI Analysis
Top Page
Invesco S&P Smallcap 600 Pure Value ETF (RZV)
Rating:60Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered strong gains so far this year and in recent months, showing solid momentum in its strategy.
Broad Sector Diversification
Holdings spread across many sectors, including consumer, industrials, technology, and health care, help reduce the impact if any one area of the market struggles.
Multiple Strong Top Holdings
Several of the largest positions, such as Ichor Holdings, Acadia Healthcare, and ArcBest, have shown strong year-to-date performance, supporting the fund’s overall results.
Negative Factors
High U.S. Concentration
Almost all assets are invested in U.S. companies, offering little geographic diversification if the U.S. market faces a downturn.
Heavy Tilt to Consumer Cyclical Stocks
A large allocation to consumer cyclical companies means the fund can be more sensitive to changes in economic conditions and consumer spending.
Moderate Expense Ratio
While not extremely high, the fund’s expense ratio is a noticeable ongoing cost that slightly reduces investors’ net returns over time.
RZV vs. SPDR S&P 500 ETF (SPY)
AUM303.31M
RegionNorth America
Expense Ratio0.35%
Beta0.98
IssuerInvesco
Inception DateMar 01, 2006
Dividend Yield1.38%
Asset ClassEquity
Index TrackedS&P Small Cap 600 Pure Value
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume7,479
30 Day Avg. Volume7,823
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
171.43Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering156
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
RZV Summary
RZV is the Invesco S&P Smallcap 600 Pure Value ETF, which follows the S&P SmallCap 600 Pure Value Index. It focuses on smaller U.S. companies that appear cheap based on their financials, aiming to find stocks that may be undervalued. The fund spreads money across many sectors, including consumer, industrial, and tech businesses. Well-known names in the fund include Newell Brands and Cracker Barrel. An investor might choose RZV for growth potential and diversification into smaller companies. However, small-cap stocks can be very volatile, so the ETF’s price can move up and down more than the overall market.
How much will it cost me?The Invesco S&P Smallcap 600 Pure Value ETF (RZV) has an expense ratio of 0.35%, which means you’ll pay $3.50 per year for every $1,000 invested. This is slightly higher than average because it is focused on a niche strategy of actively tracking small-cap value stocks, which requires more management compared to broad, passively managed ETFs.
What would affect this ETF?The Invesco S&P Smallcap 600 Pure Value ETF (RZV) could benefit from a strong U.S. economy, as small-cap stocks often thrive during periods of economic growth and consumer spending, particularly in sectors like Consumer Cyclical and Financials, which have significant weight in the ETF. However, rising interest rates or economic slowdowns could negatively impact small-cap companies, as they tend to have higher borrowing costs and are more sensitive to market volatility. Additionally, sector-specific challenges, such as fluctuating energy prices or changes in consumer behavior, could influence the performance of top holdings like ViaSat and Par Pacific Holdings.
RZV Top 10 Holdings
RZV is leaning hard into U.S. small-cap value, with a consumer tilt that makes it sensitive to the economic mood. MarineMax has been one of the brighter spots lately, rising on short-term momentum despite underlying financial strains, while Edgewell Personal Care and Newell Brands are grinding higher but still feel like recovery stories rather than clear winners. ManpowerGroup and Acadia Healthcare are more mixed, with operational challenges keeping a lid on gains. Overall, no single name dominates, but the fund’s small, cyclical U.S. exposure is steering performance.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ManpowerGroup | 2.25% | $6.84M | $2.88B | 50.22% | 54 Neutral | |
| Marinemax | 2.00% | $6.08M | $1.15B | 97.13% | 51 Neutral | |
| Acadia Healthcare | 1.74% | $5.31M | $2.62B | 18.59% | 61 Neutral | |
| Newell Brands | 1.64% | $5.00M | $2.60B | -4.38% | 49 Neutral | |
| Concentrix | 1.64% | $5.00M | $1.96B | -40.24% | 69 Neutral | |
| Edgewell Personal Care | 1.62% | $4.93M | $1.33B | 23.38% | 58 Neutral | |
| Ichor Holdings | 1.51% | $4.59M | $2.11B | 234.00% | 49 Neutral | |
| Patterson-UTI | 1.49% | $4.55M | $4.74B | 119.05% | 56 Neutral | |
| Vestis Corporation | 1.48% | $4.49M | $1.75B | 190.79% | 58 Neutral | |
| ArcBest | 1.42% | $4.34M | $3.15B | 86.42% | 66 Neutral |
RZV Technical Analysis
Neutral
―
Price Trends
149.81
Negative
143.95
Positive
134.26
Positive
Market Momentum
-0.24
Positive
45.60
Neutral
67.60
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RZV, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 150.10, equal to the 50-day MA of 149.81, and equal to the 200-day MA of 134.26, indicating a neutral trend. The MACD of -0.24 indicates Positive momentum. The RSI at 45.60 is Neutral, neither overbought nor oversold. The STOCH value of 67.60 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for RZV.
RZV Peer Comparison
Comparison Results
Performance Comparison
RZV
Invesco S&P Smallcap 600 Pure Value ETF
148.23
31.81
27.32%
ISCV
iShares Morningstar Small Cap Value ETF
―
―
―
OSCV
Opus Small Cap Value ETF
―
―
―
XSVM
Invesco S&P SmallCap Value with Momentum ETF
―
―
―
FYT
First Trust Small Cap Value AlphaDEX Fund
―
―
―
TSCV
Thrivent Small Cap Value ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents